Vertex Pharmaceuticals / CRISPR Therapeutics

    Approach: Gene Editing

    Status: Preclinical

    Press Release announcing Vertex / CRISPR Therapeutics collaboration

    Patent Application

    4.27.20 Press Release announcing Vertex / Affinia deal for AAV delivery technology

    2.15.22 Press Release announcing CRISPR earned $12.5 million milestone from Vertex related to advancement of myotonic dystrophy drug candidate.